These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24274089)

  • 1. Clustering of transcriptional profiles identifies changes to insulin signaling as an early event in a mouse model of Alzheimer's disease.
    Jackson HM; Soto I; Graham LC; Carter GW; Howell GR
    BMC Genomics; 2013 Nov; 14():831. PubMed ID: 24274089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Hypothalamic-Pituitary-Adrenal Axis, Hypothalamic-Pituitary-Gonadal Axis and Insulin Signaling in the Pathophysiology of Alzheimer's Disease.
    Ahmad MH; Fatima M; Mondal AC
    Neuropsychobiology; 2019; 77(4):197-205. PubMed ID: 30605907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease.
    Long-Smith CM; Manning S; McClean PL; Coakley MF; O'Halloran DJ; Holscher C; O'Neill C
    Neuromolecular Med; 2013 Mar; 15(1):102-14. PubMed ID: 23011726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Pedrós I; Petrov D; Allgaier M; Sureda F; Barroso E; Beas-Zarate C; Auladell C; Pallàs M; Vázquez-Carrera M; Casadesús G; Folch J; Camins A
    Biochim Biophys Acta; 2014 Sep; 1842(9):1556-66. PubMed ID: 24887203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.
    Bomfim TR; Forny-Germano L; Sathler LB; Brito-Moreira J; Houzel JC; Decker H; Silverman MA; Kazi H; Melo HM; McClean PL; Holscher C; Arnold SE; Talbot K; Klein WL; Munoz DP; Ferreira ST; De Felice FG
    J Clin Invest; 2012 Apr; 122(4):1339-53. PubMed ID: 22476196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3xTg-AD mice exhibit an activated central stress axis during early-stage pathology.
    Hebda-Bauer EK; Simmons TA; Sugg A; Ural E; Stewart JA; Beals JL; Wei Q; Watson SJ; Akil H
    J Alzheimers Dis; 2013; 33(2):407-22. PubMed ID: 22976078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
    Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
    Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
    Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentivirus-Mediated Expression of Human Secreted Amyloid Precursor Protein-Alpha Promotes Long-Term Induction of Neuroprotective Genes and Pathways in a Mouse Model of Alzheimer's Disease.
    Ryan M; Tan VTY; Thompson N; Guévremont D; Mockett BG; Tate WP; Abraham WC; Hughes SM; Williams J
    J Alzheimers Dis; 2021; 79(3):1075-1090. PubMed ID: 33386801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease.
    Stöhr O; Schilbach K; Moll L; Hettich MM; Freude S; Wunderlich FT; Ernst M; Zemva J; Brüning JC; Krone W; Udelhoven M; Schubert M
    Age (Dordr); 2013 Feb; 35(1):83-101. PubMed ID: 22057897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain gene expression of a sporadic (icv-STZ Mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer's disease.
    Chen Y; Tian Z; Liang Z; Sun S; Dai CL; Lee MH; LaFerla FM; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
    PLoS One; 2012; 7(12):e51432. PubMed ID: 23236499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.
    Nakamura N; Ohyagi Y; Imamura T; Yanagihara YT; Iinuma KM; Soejima N; Murai H; Yamasaki R; Kira JI
    J Alzheimers Dis; 2017; 58(4):1151-1161. PubMed ID: 28550243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between age, stress and insulin on cognition: implications for Alzheimer's disease.
    Solas M; Aisa B; Mugueta MC; Del Río J; Tordera RM; Ramírez MJ
    Neuropsychopharmacology; 2010 Jul; 35(8):1664-73. PubMed ID: 20182419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in Cerebral Cortical Glucose and Glutamine Metabolism Precedes Amyloid Plaques in the APPswe/PSEN1dE9 Mouse Model of Alzheimer's Disease.
    Andersen JV; Christensen SK; Aldana BI; Nissen JD; Tanila H; Waagepetersen HS
    Neurochem Res; 2017 Jun; 42(6):1589-1598. PubMed ID: 27686658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,4-Dihydroxyphenylethanol Assuages Cognitive Impulsivity in Alzheimer's Disease by Attuning HPA-Axis via Differential Crosstalk of α7 nAChR with MicroRNA-124 and HDAC6.
    ArunSundar M; Shanmugarajan TS; Ravichandiran V
    ACS Chem Neurosci; 2018 Dec; 9(12):2904-2916. PubMed ID: 29901389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease.
    Kim B; Elzinga SE; Henn RE; McGinley LM; Feldman EL
    Neurobiol Dis; 2019 Dec; 132():104541. PubMed ID: 31349033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional Remodeling in Primary Hippocampal Astrocytes from an Alzheimer's Disease Mouse Model.
    Ruffinatti F; Tapella L; Gregnanin I; Stevano A; Chiorino G; Canonico PL; Distasi C; Genazzani AA; Lim D
    Curr Alzheimer Res; 2018; 15(11):986-1004. PubMed ID: 29895250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.